Dr. Robert Vigersky, Chief Medical Officer at Medtronic Diabetes, discusses the evolution of the insulin pump, virtually training type 1 diabetics how to use an insulin pump, the recent FDA approval of the Minimed™ 770G Insulin Pump System with smartphone connectivity, and Medtronic’s recent acquisition of Companion Medical’s Smart Insulin Pen.
Robert A. Vigersky, M.D. is Senior Medical Director, Diabetes Group, Medtronic, and Professor of Medicine at the Uniformed Services University of the Health Sciences. He also acts as the Diabetes Medical Officer for the Diabetes Group at Medtronic.He graduated as the Valedictorian from Boston University School of Medicine, did his Internal Medicine training at The Johns Hopkins Hospital, and completed a 3-year Fellowship in Endocrinology at the NIH. He has had a distinguished career that has included Academia (at Walter Reed where he established the Diabetes Institute), Private Practice (where he was President of the Endocrine and Diabetes Group of Washington and Director of the Diabetes Treatment Center at Georgetown University Hospital and the Washington Hospital Center), and Industry (at Medtronic). He has been an active participant in the Endocrine Society where established Clinical Practice Guideline program and served as President from 2009-2010 and the Diabetes Technology Society which gave him its Leadership Award in 2011. Dr. Vigersky has published over 280 scholarly papers and abstracts focusing on the use of technology to improve outcomes of patients with diabetes.